Literature DB >> 30181207

Retraction: Embelin Suppresses Osteoclastogenesis Induced by Receptor Activator of NF-κB Ligand and Tumor Cells In vitro through Inhibition of the NF-κB Cell Signaling Pathway.

.   

Abstract

Year:  2018        PMID： 30181207      PMCID： PMC6181130          DOI： 10.1158/1541-7786.MCR-18-0818

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN： 1541-7786            Impact factor:   5.852


× No keyword cloud information.
  1 in total

1.  Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.

Authors:  Simone Reuter; Sahdeo Prasad; Kanokkarn Phromnoi; Ramaswamy Kannappan; Vivek R Yadav; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2010-09-08       Impact factor: 5.852
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.